0001597264-14-000002.txt : 20141120
0001597264-14-000002.hdr.sgml : 20141120
20141120114326
ACCESSION NUMBER: 0001597264-14-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20141120
DATE AS OF CHANGE: 20141120
EFFECTIVENESS DATE: 20141120
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Blueprint Medicines Corp
CENTRAL INDEX KEY: 0001597264
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-228724
FILM NUMBER: 141238041
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-374-7580
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
D
1
primary_doc.xml
X0707
D
LIVE
0001597264
Blueprint Medicines Corp
215 FIRST STREET
Suite 340/350
CAMBRIDGE
MA
MASSACHUSETTS
02142
617-374-7580
DELAWARE
None
None
Corporation
true
Jeffrey
W.
Albers
215 First Street
Suite 340/350
Cambridge
MA
MASSACHUSETTS
02142
Executive Officer
Director
Kyle
Kuvalanka
215 First Street
Suite 340/350
Cambridge
MA
MASSACHUSETTS
02142
Executive Officer
Christine
Bellon
215 First Street
Suite 340/350
Cambridge
MA
MASSACHUSETTS
02142
Executive Officer
Christoph
S.
Lengauer
215 First Street
Suite 340/350
Cambridge
MA
MASSACHUSETTS
02142
Executive Officer
Alexis
Borisy
215 First Street
Suite 340/350
Cambridge
MA
MASSACHUSETTS
02142
Director
Stephen
Knight
215 First Street
Suite 340/350
Cambridge
MA
MASSACHUSETTS
02142
Director
Daniel
Lynch
215 First Street
Suite 340/350
Cambridge
MA
MASSACHUSETTS
02142
Director
Nicholas
Lydon
215 First Street
Suite 340/350
Cambridge
MA
MASSACHUSETTS
02142
Director
David
Schenkein
215 First Street
Suite 340/350
Cambridge
MA
MASSACHUSETTS
02142
Director
Thilo
Schroeder
215 First Street
Suite 340/350
Cambridge
MA
MASSACHUSETTS
02142
Director
Biotechnology
Decline to Disclose
- 06b
false
2014-11-10
false
true
false
0
50000000
50000000
0
false
29
0
0
0
false
Blueprint Medicines Corp
Kyle D. Kuvalanka
Kyle D. Kuvalanka
Chief Business Officer
2014-11-20